Announcement Microbiome Labs, a champion in microbiome-related solutions, inaugurated DigestMate™, a probiotic and 2-in-1 digestive enzyme formula. As observed, the digestive health issues have peaked in the American region, affecting an infinite number of lives, and the demand for innovative...
Announcement Capricor has again come up with the pivotal results for DMD cardiomyopathy therapy after the rejection. After six months of receiving the shocking rejection for Capricor’s cell therapy deramiocel, which showed a steady decline in cardiac function and a noteworthy benefit in uppe...
Announcement With the year ending, the UK/EU healthcare regulatory body bundled up new rules and specified the new technologies (AI/ML) adoption to achieve a successful start. The new UK clinical trial rules will be officially unveiled in 2026. Alongside, the EU Biotech Act has exponentially reach...
Announcement enGene Holdings Inc., a known clinical level non-viral genetic medicines company, proudly declared its detalimogene voraplasmid selection by the FDA for its Pilot program to contribute to the manufacturing readiness. The detalimogene voraplasmid is also known as detalimogene and was pr...
Announcement PharmaTher Holdings Ltd., a known speciality life sciences company dedicated to unveiling the therapeutic capabilities of ketamine for neuropsychiatric disorders, has confirmed its closing of the existing declared sale of its Abbreviated New Drug Application (ANDA#217858) for Ketamine...
Announcement tiakis Biotech AG, a leading clinical-level biopharmaceutical company conquering novel therapeutics for cardiovascular and life-threatening pulmonary disease, confirmed the completion of its robust data package to upgrade Tiprelestat into a Phase 2 clinical trial in Pulmonary Arterial...
Announcement TempraMed Technologies Ltd., a leading innovator of advanced temperature-controlled medical devices, is honoured to announce its definitive exclusive distribution partnership with Dolfin Sağlık Ürünleri. The intention of TempraMed to join hands with this Turkish company is ...
Announcement Cleveland Diagnostics, Inc., an advanced commercial-level precision oncology company, proudly shared its FDA approval news for its IsoPSA® in vitro diagnostic (IVD) kit via the Premarket Approval (PMA) process. The IsoPSA is a blood-related test referred to as an aid in the decisio...
Announcement Biolexis Therapeutics, an evolving champion in presenting best-in-class inflammation-targeted and next-generation metabolic therapies, proudly announced its selection for the two presentations at the 2nd Innovation in Obesity Therapeutics Summit. To present the company’s clinica...
Announcement Cardiol Therapeutics Inc., a clinical-level life sciences company known for modernising the anti-fibrotic and anti-inflammatory therapies for heart conditions, has released its strong and impressive data from its ARCHER study. The ARCHER study is a placebo-balanced, randomised, double ...
